1. BASF: Fit for 2012 and beyond
4Q/FY’2011 Analyst Conference
Ludwigshafen, February 24, 2012
BASF 4Q/FY’2010 Conference | February 24th, 2011

2. Forward-looking statements
This presentation includes forward-looking statements that are subject to risks and
uncertainties, including those pertaining to the anticipated benefits to be realized from the
proposals described herein. This presentation contains a number of forward-looking
statements including, in particular, statements about future events, future financial
performance, plans, strategies, expectations, prospects, competitive environment,
regulation and supply and demand. BASF has based these forward-looking statements on
its views with respect to future events and financial performance. Actual financial
performance of the entities described herein could differ materially from that projected in the
forward-looking statements due to the inherent uncertainty of estimates, forecasts and
projections, and financial performance may be better or worse than anticipated. Given these
uncertainties, readers should not put undue reliance on any forward-looking statements.
Forward-looking statements represent estimates and assumptions only as of the date that
they were made. The information contained in this presentation is subject to change without
notice and BASF does not undertake any duty to update the forward-looking statements,
and the estimates and assumptions associated with them, except to the extent required by
applicable laws and regulations.
2

3. Agenda
1 Highlights 2011
2 Outlook 2012
3 Financials Q4 2011
3

4. Record year 2011
Business performance Q4’11 vs. Q4’10 FY’11 vs. FY’10
 Sales €18.1 billion +10% €73.5 billion +15%
 EBITDA €2.9 billion +7% €12.0 billion +8%
 EBIT before special items €1.5 billion -14% €8.4 billion +4%
 EBIT €1.9 billion +15% €8.6 billion +11%
 Net income €1.1 billion +3% €6.2 billion +36%
 Reported EPS €1.23 +3% €6.74 +36%
 Adjusted EPS €1.05 -24% €6.26 +9%
 Operating cash flow €2.1 billion +80% €7.1 billion +10%
Sales development
Period Volumes Prices Portfolio Currencies
Q4’11 vs. Q4’10

(1)%  9%  2% 0%
FY’11 vs. FY’10 0%  12%  5% 
(2)%
4

5. Major achievements in 2011
Investments:
 Start-up of Nanjing expansion 
 Commissioning of Nord Stream and the OPAL pipeline 
Portfolio management:
 Completion of Cognis integration 
 Start of business of Styrolution JV with Ineos 
 Divestiture of K+S shares and agreement to sell fertilizer assets (Antwerp)

Operational excellence:
 Completion of NEXT program – annual earnings contribution of more than 
€1 billion as of 2012
5

6. Strong and profitable growth in
emerging markets
Sales BASF Group excluding Oil & Gas
in billion € by location of customer
61
60
34% Emerging markets
40
28
Developed markets*
22%
20 * BASF definition: Developed markets
include EU15, Norway, Switzerland,
North America, Japan, Australia,
New Zealand
0
2001 2011
6

7. €2.6 billion premium on cost of capital
achieved in 2011
Premium on cost of capital
in billion €
4,000
Target first 3.5
established
3,000 2.9
2.6
2.4
2.0 2.1
2,000
1.6
1,000
0
-0.2
-0.6 -0.6
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Cost of capital rate: 9% 11%
7

8. Attractive shareholder returns
Dividend per share (€) Key facts
 Average annual dividend
Proposal: increase of 15.2%
2.50
2.50
2.5 (2002-2011)
2.20
2.00
2.0
1.95 1.95  Attractive dividend yield of
1.70 4.6% in 2011**
1.50
1.50
1.5  Dividend yield above 3% in any
1.00 given year since 2002
1.00
1.0 0.85
0.70 0.70
0.5
0.50
0.0
2002 2005 2008 2011
Yield* 3.9% 3.1% 3.2% 3.1% 4.1% 3.8% 7.0% 3.9% 3.7% 4.6%
* Dividend yield based on share price at year-end ** Based on BASF share price of €53.89 on
Dec 30, 2011
8

9. Delivering consistent, long-term value
Long-term performance January 2002 – December 2011
(average annual performance with dividends reinvested)
Last 5 years
+14.1% BASF +12.5%
-1.9% Euro Stoxx 50 –7.4%
+1.3% DAX 30 –2.2%
+7.2% MSCI World Chemicals +2.4%
-3 0 3 6 9 12 15
9

10. Agenda
1 Highlights 2011
2 Outlook 2012
3 Financials Q4 2011
10

11. Outlook 2012
Expectations for global economy
2011 Forecast 2012
GDP 2.7% 2.7%
Chemicals (excl. Pharma) 4.8% 4.1%
Industrial production 4.7% 4.1%
US$ / Euro 1.39 1.30
Oil price (US$ / bbl) 111 110
11

12. Outlook 2012 by region
Chemical production (excl. pharma)
2011 Forecast 2012
World 4.8% 4.1%
EU-27 1.6% 0.8%
USA 2.1% 2.2%
Asia (excl. Japan) 11.1% 8.0%
Japan -3.1% 3.4%
South America 4.7% 3.9%
12

13. Outlook BASF Group 2012
 BASF Group aims to exceed the record levels of sales and EBIT before
special items achieved in 2011.
 In H1 2012, BASF will most likely not achieve the exceptionally high
results of the comparable period in 2011. However, we aim to outperform
H2 2011.
 More specifically, we plan to increase sales and earnings in all our
business segments with the exception of the segment Chemicals.
 In 2012, BASF will strive to earn again a high premium on cost of capital.
13

14. Agenda
1 Highlights 2011
2 Outlook 2012
3 Financials Q4 2011
14

15. Chemicals
Price increases could not compensate for lower volumes
Q4’11 segment sales (million €) vs. Q4’10 EBIT before special items (million €)
Intermediates Inorganics 600 2,302
2,441
537
631 355
-4% +9% 2,000
381
400
€3,122
+6% 200
1,000
Petrochemicals
2,136 0 0
+9% Q4 '10 Q4 '11 FY '10 FY '11
Sales development
Period Volumes Prices Portfolio Currencies
Q4’11 vs. Q4’10  (8)%  7%  6%  1%
 16%  2%
 
FY’11 vs. FY’10 (1)% (3)%
15

16. Plastics
Weaker demand led to receding margins
Q4’11 segment sales (million €) vs. Q4’10 EBIT before special items (million €)
Polyurethanes 300 285 1,284
1,203
1,395 1.200
+2%
200
€2,573 800
110
+5% 100
400
Performance
Polymers
0 0
1,178
Q4 '10 Q4 '11 FY '10 FY '11
+8%
Sales development
Period Volumes Prices Portfolio Currencies
Q4’11 vs. Q4’10  (3)%  6%  1%  1%
FY’11 vs. FY’10  4%  10% 0%
 (2)%
16

17. Performance Products
Earnings burdened by destocking and integration costs
Q4’11 segment sales (million €) vs. Q4’10 EBIT before special items (million €)
294
Care Chemicals 300 2,000
1,727
1,180 Performance 1,554
Chemicals 220
+55% 1,500
822 200
Nutrition €3,629 +6% 1,000
& Health
442 +19% 100
+15% 500
Paper Chemicals Dispersions 0 0
390 & Pigments Q4 '10 Q4 '11 FY '10 FY '11
-4% 795
+9%
Sales development
Period Volumes Prices Portfolio Currencies
Q4’11 vs. Q4’10  (6)%  6%  19% 0%
  25%
FY’11 vs. FY’10  (1)% 6%
 (2)%
17

18. Functional Solutions
Continuous strong earnings improvement
Q4’11 segment sales (million €) vs. Q4’10 EBIT before special items (million €)
Catalysts Construction Chemicals 100 88 600 559
1,595 536 467
+17% +4% 80
400
€2,870 60
+12% 40 33
200
20
Coatings
739 0 0
+8% Q4 '10 Q4 '11 FY '10 FY '11
Sales development
Period Volumes Prices Portfolio Currencies
  8%
Q4’11 vs. Q4’10 6%  (1)%  (1)%
FY’11 vs. FY’10  9%  10%  1%  (3)%
18

19. Agricultural Solutions
Another record year for Crop Protection
Q4’11 segment sales (million €) vs. Q4’10 EBIT before special items (million €)
1,000 50 900 810
845 822 42 41 749
800 40
600
600 30
400 20
300
200 10
0 0 0
Q4 Q4 Q4 '10 Q4 '11 FY '10 FY '11
2010 2011
Sales development
Period Volumes Prices Portfolio Currencies
 2%
Q4’11 vs. Q4’10
 (5)% 0% 0%
FY’11 vs. FY’10  6% 0% 0%  (3)%
19

20. Oil & Gas
Higher oil prices improved sales and net income
Q4’11 segment sales (million €) vs. Q4’10 EBIT before special items / Net income (million €)
2,430
Exploration & 800 713 2,500
685 2,111
Production
1,017 2,000
600
-4%
€3,940 400
1,500
1,064
276 923
+33% 230 1,000
564
Natural Gas 200
500
Trading
2,923 0 0
+53% Q4 '10 Q4 '11 FY '10 FY '11
EBIT bSI Natural Gas Trading Net income
EBIT bSI Exploration & Production
Sales development
Period Volumes Prices/Currencies Portfolio
Q4’11 vs. Q4’10  7%  25%  1%
 23%

FY’11 vs. FY’10 (11)% 0%
20

21. Review of “Other”
Million € Q4 2011 Q4 2010 2011 2010
Sales 1,112 1,590 6,275 5,851
thereof Styrenics 714 2,393 2,848
EBIT before special items (11) (139) (404) (648)
thereof Corporate research (92) (96) (348) (323)
Group corporate costs (74) (66) (246) (226)
Currency results, hedges and other (107) (229) (199) (460)
valuation effects
Styrenics, fertilizers, other businesses 65 142 408 387
Special items 623 149 582 (59)
EBIT 612 10 178 (707)
21

22. Excellent operating cash flow in 2011
Full Year 2011 (billion €)
9
8
7 (3.4)
6 7.1
0.5
5
(2.5)
4
3
(1.8)
2 (2.4)
1.2
1 1.5 2.0
0
Cash Operating Capex* Acquisitions Dividends Debt Other cash Cash
12/31/10 CF & Divestitures reduction inflows 12/31/11
* Payments related to intangible assets and property, plant and equipment
22

23. Balance sheet remains strong
Balance sheet 2011 vs. 2010 (billion €) Highlights 2011
 Reduction of long-term assets
61.2 61.2 by €0.4 billion, thereof
59.4 59.4
– €1.1 billion in other financial
Stock- assets
22.7 25.4 holders’ – €0,5 billion increase of at
Long-term Equity
assets 34.5 34.1 equity investments
 Addition of
Financial
15.0 13.0 debt – €1.4 billion of inventories
Inventories 8.7 10.1 – €0.7 billion of receivables
Accounts
receivable 10.2 10.9 22.8 Other  Equity ratio of 41.5%
21.7 liabilities
Other assets 4.5 4.1  Net debt: €11.0 billion
Liquid funds 1.5 2.0
Dec 31 Dec 31 Dec 31 Dec 31  Net debt EBITDA ratio: 0.9
2010 2011 2010 2011
23

25. BASF Crop Protection
Financial results FY 2011
million € FY 2011 FY 2010 ∆% ∆% CER
Sales* 4,165 4,033 3% 6%
EBITDA** 983 938 5% 11%
EBITDA margin** 23.6% 23.3% - -
EBIT** 810 749 8% 16%
EBIT margin** 19.4% 18.6% - -
Assets (as of Dec. 31) 5,350 5,063 6% 6%
Research and development expenses 412 393 5% 6%
* sales drivers 2011: volumes 6%, prices 0%, currencies -3%
** before special items
CER = at constant exchange rates
Sales and earnings record despite currency headwinds. Q4 2011 prices +2%
25

26. BASF Crop Protection
Sales by indication FY 2011
Total sales 2011 to third parties Key facts
in million €  Fungicides:
Global volume gains supported
by high demand in emerging
Fungicides Herbicides markets, Plant Health business.
1,904 (+12%) 1,401 (+2%) Xemium launch started in EU
 Herbicides:
€4,165 Higher emerging markets
(+6%) demand overcompensates
lower sales in North America
 Insecticides:
Insecticides/Other Continued growth in most
860 (+1%) product lines (e.g. Seed
Solutions®), portfolio
optimization
In brackets growth at constant exchange rates in % vs. prior year
Sales growth particularly driven by fungicides
26

27. BASF Crop Protection
Sales by region FY 2011
Total sales 2011 to third parties Key facts
in million €  Europe:
Strong growth contribution from
herbicides, Eastern Europe
North America Europe
 North America:
965 (+1%) 1,659 (+7%)
High demand for Plant Health
products. Herbicide business
€4,165 affected by acreage reductions,
(+6%) competition in imidazolinones
Asia Pacific
487 (+12%)  South America, Africa, ME:
Intense use of Fipronil-based
South America, insecticides, AgCelence® thrived
Africa, Middle East
 Asia Pacific:
1,054 (+7%) Significantly increased demand
for fungicides and herbicides in
In brackets growth at constant exchange rates in % vs. prior year emerging markets
Regionally balanced business
Global volume growth, especially in emerging markets
27